Visit https://www.peervoice.com/CPF860 to view the entire programme with slides. After completing “Managing Risk of Persistent Acute Kidney Injury in the ICU: The RUBY Study”, participants will be able to: Describe the rationale, design, and key findings of a study to identify biomarkers for patients at risk of persistent severe acute kidney injury (AKI); Explain the role of urinary CCL14 as a biomarker for stratifying patients at risk for persistent severe AKI as demonstrated in the study; and Translate the use of biomarkers for management of patients with, or at risk of, persistent severe AKI.